Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

The buyer, Viscogliosi Brothers, will call the company VB Spine. Stryker also reported operating results and offered its ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Stryker's Mako shoulder robot earned FDA approval in December, Jason Beach, vice president of finance and investor relations, said in a Jan. 28 earnings call.

Once complete, the new company will have exclusive access to Stryker’s Mako Spine robotic-assisted surgical device and Copilot surgical assistance technology for use with VB Spine’s implants.

Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...

Stryker plans to sell its U.S. spinal implants business, the company said Jan. 28. The U.S. spine segment will be sold to investment firm Viscogliosi Brothers, and that group will create VB Spine, ...

Here are eight things for ASCs to know about the sale: 1. Stryker's U.S. spine segment will be sold to investment firm Viscogliosi Brothers. 2. That group will create VB Spine, which will be a ...

Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Stryker SYK in the last three months. The table below provides a snapshot of their recent ...

Stryker Corporation SYK recently announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi ...

Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall ...